Seebri Breezhaler Inhalation Caps. (Glycopyrronium Capsule) 50 mcg

Seebri Breezhaler Inhalation Capsules contain glycopyrronium bromide, a long-acting muscarinic antagonist used to maintain airflow in the lungs. Store below 25°C and keep capsules in the blister until use. This product is designed for inhalation via the Breezhaler device.

Strength

50 mcg

Pack Size

30s

Storage

Below 25°C

Manufacturer / TM Owner

Novartis Pharma

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Glycopyrronium inhalation capsules are used to help open the airways and improve breathing in adults with chronic obstructive pulmonary disease (COPD). They belong to a class of medications known as bronchodilators, which work by relaxing the muscles around the airways. This medication is not intended for immediate relief of breathing problems.

Side Effects

After inhalation, glycopyrronium begins to act by widening the air passages in the lungs, making it easier to breathe over time. Users may notice improved airflow and reduced wheezing or shortness of breath during daily activities. Effects typically develop gradually with regular use.

Precautions & Warnings

Keep inhalation capsules sealed in the blister strip until use to protect from moisture. Store the device and capsules at room temperature, below 25°C. Do not swallow the capsules; they are meant for inhalation only using the Breezhaler device. Keep out of reach of children.

Avoid Interactions

This medication may interact with other anticholinergic drugs, which can increase the risk of side effects like dry mouth or urinary retention. Avoid combining it with other inhaled medications unless directed by a healthcare provider. Always inform your doctor about all medications you are taking.

Frequently Asked Questions

Insert a capsule into the Breezhaler device, pierce it, and inhale the powder fully. Do not swallow the capsule; it is for inhalation only.

Take the missed dose as soon as you remember, unless it is almost time for the next dose. Do not take two doses at once.

No, this medication is not for immediate relief. Use your rescue inhaler for sudden symptoms.

Store capsules in the original blister pack and keep them below 25°C. Protect from moisture.

Common effects may include dry mouth, throat irritation, or cough. Report persistent issues to a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.